# InfoBionic

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/infobionic

- Industry: Medical Devices & Equipment
- Headquarters: Chelmsford, US
- Website: www.infobionic.com/
- Total disclosed funding: $73M
- Latest round: Series D (Sep 29, 2023)
- Investors on record: 18

## About

InfoBionic, Inc., based in Chelmsford, Massachusetts, specializes in advanced remote cardiac monitoring solutions, offering AI-enabled technologies that enhance cardiac care through real-time data analysis and monitoring.Founded in 2011, InfoBionic, Inc. focuses on developing innovative remote cardiac monitoring solutions. The company has attracted significant investment, notably raising USD 57.765 mn in Series D funding on September 29, 2023, from investors including Mayo Clinic and Excel Venture Management. The firm operates from its headquarters in Chelmsford, US, and has completed a total of 11 deals to date.InfoBionic, Inc. specializes in advanced remote cardiac monitoring solutions, with its flagship product, the MoMe ARC® platform. This system utilizes AI-enabled clinical workflows and high-quality ECG monitoring, offering configurable hospital-grade monitoring from various locations. The MoMe ARC® platform includes a range of biosensor lead sets for diverse patient needs, enhancing cardiac care through real-time data analysis. InfoBionic serves healthcare institutions, major hospitals, and specialized cardiac clinics across the United States, while also exploring international markets.InfoBionic generates revenue primarily through partnerships and subscriptions to its MoMe ARC® monitoring service. Clients, including healthcare providers and institutions, utilize the AI-enabled technology for remote cardiac telemetry, with revenue generated from subscription fees and service agreements for installation, maintenance, and support. The company’s partnerships enhance the integration of its solutions into existing cardiac care protocols, improving patient outcomes and operational efficiencies.Following its most recent Series D funding round of USD 57.765 mn in September 2023, InfoBionic plans to utilize these resources to support business expansion and promote the launch of its new MoMe® ARC system. The company aims to target new geographic markets and healthcare institutions, with specific plans for expansion into international regions to be announced in the near future.

## Funding rounds

- Series D, Sep 29, 2023, $58M — Safeguard Scientifics, Mayo Clinic, Excel Venture Management, Blue Cross & Blue Shield of Kansas, Blue Cross and Blue Shield of Massachusetts, Inc. Retirement Income Trust
- Series B, Jul 24, 2015, $8.2M — Safeguard Scientifics, Excel Venture Management, Zaffre Investments
- Series B, Nov 19, 2014 — Safeguard Scientifics, Keiretsu Forum, Excel Venture Management, Launchpad Venture Group, Boynton Angels, HTC Corporation, Cherrystone Angel Group, The Indus Entrepreneurs, Beta Fund, Zaffre Investments
- Series B, Apr 7, 2014, $6.6M — Safeguard Scientifics, Keiretsu Forum, Broadview Ventures, Launchpad Venture Group, Mass Medical Angels, Boynton Angels, HTC Corporation, Cherrystone Angel Group, The Indus Entrepreneurs, Beta Fund, Boardwalk Financial Group LLC
- Series A, Mar 11, 2013 — Tech Coast Angels, HealthTech Capital, Beta Fund

## Investors

- Tech Coast Angels — Series A
- HealthTech Capital — Series A
- Beta Fund (https://capitalatlas.ai/funds/beta-fund) — Series A, Series B
- Safeguard Scientifics (https://capitalatlas.ai/funds/safeguard-scientifics) — Series B, Series D
- Keiretsu Forum — Series B
- Broadview Ventures (https://capitalatlas.ai/funds/broadview-ventures) — Series B
- Launchpad Venture Group (https://capitalatlas.ai/funds/launchpad-venture-group) — Series B
- Mass Medical Angels — Series B
- Boynton Angels — Series B
- HTC Corporation — Series B
- Cherrystone Angel Group (https://capitalatlas.ai/funds/cherrystone-angel-group) — Series B
- The Indus Entrepreneurs — Series B
- Boardwalk Financial Group LLC — Series B
- Excel Venture Management (https://capitalatlas.ai/funds/excel-venture-management) — Series B, Series D
- Zaffre Investments (https://capitalatlas.ai/funds/zaffre-investments) — Series B
- Mayo Clinic — Series D
- Blue Cross & Blue Shield of Kansas — Series D
- Blue Cross and Blue Shield of Massachusetts, Inc. Retirement Income Trust — Series D